Fact CheckerSign in

NCT05524012Active, not recruiting

Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal Cancer

Planning Adaptive Treatment by Longitudinal Response Assessment Implementing MR Imaging, Liquid Biopsy and Analysis of Microenvironment During Neoadjuvant Treatment of Rectal Cancer (PRIMO)

Source: ClinicalTrials.gov · Last updated 6 Aug 2026

Brief summary (registry, in English)

This pilot study aims to trial multimodal early response assessment to enable therapy adaptions in the context of non-operative therapy strategies of locally advanced rectal cancer (LARC) for development of a non-invasive response prediction model.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
40 (estimated)
First submitted
30 Aug 2022
Start date
30 Nov 2022
Primary completion date
31 Jan 2026
Lead sponsor
Jena University Hospital
NCT number
NCT05524012

What you commit to

  • Study type: Observational
  • Planned participants: 40
  • From 30 Nov 2022 to the primary completion date, 31 Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • locally advanced rectal cancer (LARC): UICC Stage II/III
  • no severe cardiac or lung disease
  • no severe hepatic disorders (liver enzymes \<2.5 NR) or restrictions of renal function (GFR \> 30ml/min)
  • no severe cytopenia (Neutrocytes \>= 3 Gpt/l; Thrombocytes \>= 100 Gpt/l; Hemoglobin \>6mmol/l)
  • no homozygotic DPD deficiency
  • no other neoplasms requiring therapy
  • no earlier radiotherapy of the pelvis or earlier chemotherapy
  • no contraindications for MRI

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Radiotherapy and Radiation Oncology, Jena University Hospital
Coordinator of this site? Confirm its status
JenaGermanyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.